Kiyatec
Latest round
- Series C
Last raised
- Nov 2022
Total raised
- $18M
Investors
- 6
About Kiyatec
Founded in 2010 in Greenville, US, Kiyatec Inc. focuses on developing advanced oncology solutions.060 mn. The firm has completed 8 total deals, with the most recent deal occurring on May 18, 2023.Kiyatec's core offerings center around its innovative 3D Predict platform, designed to revolutionize cancer care by providing patient-specific predictions of response to drug therapies prior to treatment. Utilizing advanced 3D cell culture technology, it simulates tumor behavior in response to therapeutic agents, allowing oncologists to tailor treatment plans effectively.Kiyatec operates on a B2B revenue model, partnering with healthcare providers and pharmaceutical companies to offer its 3D Predict platform and related services. This model includes subscription agreements for ongoing platform use, as well as collaborative partnerships for clinical research and product development.In May 2023, Kiyatec Inc. The company aims to expand its market reach by targeting new geographic regions, with specific plans for further penetration into Europe and Asia by the end of 2024. Additionally, Kiyatec is focused on the development of new features for the 3D Predict platform to enhance its capabilities and user experience.
Who invested in Kiyatec
6 investors across 2 rounds
See all investors in Kiyatec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kiyatec
Who invested in Kiyatec?
Kiyatec has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kiyatec raised?
Kiyatec has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kiyatec last raise money?
Kiyatec's most recent round on record is a Series C, in Nov 2022.
What does Kiyatec do?
Founded in 2010 in Greenville, US, Kiyatec Inc.
Where is Kiyatec headquartered?
Kiyatec is headquartered in Greenville, US.
Which VCs invest in companies like Kiyatec?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kiyatec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Kiyatec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.